Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham P Cook

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Molecular Immunology|December 25, 2013
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytesJehan J El-Jawhari, Yasser M El-Sherbiny, Gina B Scott, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Oncolytic Maraba virus MG1 mediates direct and natural killer cell-dependent lysis of Ewing sarcomaTyler Barr, Victoria A Jennings, Elizabeth A Roundhill, et al.
Cancers|October 29, 2025
Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing SarcomaTyler Barr, Victoria A Jennings, Elizabeth A Roundhill, et al.
Blood|October 4, 2003
Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesisP Louise Coletta, Albrecht M Müller, Elena A Jones, et al.
The Journal of Clinical Investigation|April 18, 2018
β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomasJérémie Nsengimana, Jon Laye, Anastasia Filia, et al.
Pigment Cell & Melanoma Research|November 26, 2021
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro-tumourigenicityJohn Davies, Sathya Muralidhar, Juliette Randerson-Moor, et al.
Frontiers in Immunology|January 7, 2025
Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.
Frontiers in Immunology|May 7, 2025
Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatmentRebeccah J Mathews, James I Robinson, Michele Battellino, et al.
Cancer Research|February 19, 2019
Genetic and Environmental Determinants of Immune Response to Cutaneous MelanomaJoanna Poźniak, Jérémie Nsengimana, Jonathan P Laye, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Molecular Immunology|December 25, 2013
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytesJehan J El-Jawhari, Yasser M El-Sherbiny, Gina B Scott, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Oncolytic Maraba virus MG1 mediates direct and natural killer cell-dependent lysis of Ewing sarcomaTyler Barr, Victoria A Jennings, Elizabeth A Roundhill, et al.
Cancers|October 29, 2025
Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing SarcomaTyler Barr, Victoria A Jennings, Elizabeth A Roundhill, et al.
Blood|October 4, 2003
Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesisP Louise Coletta, Albrecht M Müller, Elena A Jones, et al.
The Journal of Clinical Investigation|April 18, 2018
β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomasJérémie Nsengimana, Jon Laye, Anastasia Filia, et al.
Pigment Cell & Melanoma Research|November 26, 2021
Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro-tumourigenicityJohn Davies, Sathya Muralidhar, Juliette Randerson-Moor, et al.
Frontiers in Immunology|January 7, 2025
Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.
Frontiers in Immunology|May 7, 2025
Corrigendum: Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironmentVictoria A Jennings, Reah Rumbold-Hall, Gemma Migneco, et al.
Annals of the Rheumatic Diseases|May 21, 2013
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatmentRebeccah J Mathews, James I Robinson, Michele Battellino, et al.
Cancer Research|February 19, 2019
Genetic and Environmental Determinants of Immune Response to Cutaneous MelanomaJoanna Poźniak, Jérémie Nsengimana, Jonathan P Laye, et al.
Pageof 5